These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Neuroendocrine aspects of primary endogenous depression. II. Serum dexamethasone concentrations and hypothalamic-pituitary-adrenal cortical activity as determinants of the dexamethasone suppression test response. Poland RE; Rubin RT; Lesser IM; Lane LA; Hart PJ Arch Gen Psychiatry; 1987 Sep; 44(9):790-5. PubMed ID: 3632252 [TBL] [Abstract][Full Text] [Related]
4. DST in depression is unaffected by altering the clock time of its administration. Pepper GM; Davis KL; Davis BM; Krieger DT Psychiatry Res; 1983 Feb; 8(2):105-9. PubMed ID: 6574528 [TBL] [Abstract][Full Text] [Related]
5. [Influence of depressive history on biological parameters in major depression]. Van Wijnendaele R; Hubain P; Dramaix M; Mendlewicz J; Linkowski P Encephale; 2002; 28(1):51-8. PubMed ID: 11963343 [TBL] [Abstract][Full Text] [Related]
6. Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression. Bschor T; Baethge C; Adli M; Eichmann U; Ising M; Uhr M; Müller-Oerlinghausen B; Bauer M Depress Anxiety; 2003; 17(1):43-8. PubMed ID: 12577277 [TBL] [Abstract][Full Text] [Related]
7. Use of dexamethasone suppression test in clinical psychiatry. Kalin NH; Risch SC; Janowsky DS; Murphy DL J Clin Psychopharmacol; 1981 Mar; 1(2):64-9. PubMed ID: 7298885 [TBL] [Abstract][Full Text] [Related]
8. The dexamethasone suppression and metyrapone tests in depression. Morphy MA; Fava GA; Perini GI; Molnar G; Zielezny M; Lisansky J Psychiatry Res; 1985 Jun; 15(2):153-8. PubMed ID: 3862146 [TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine aspects of primary endogenous depression. III. Cortisol secretion in relation to diagnosis and symptom patterns. Rubin RT; Poland RE; Lesser IM; Martin DJ; Blodgett AL; Winston RA Psychol Med; 1987 Aug; 17(3):609-19. PubMed ID: 3628622 [TBL] [Abstract][Full Text] [Related]
10. HPA axis abnormalities in depressed patients with normal response to the DST. Meller W; Kathol RG; Jaeckle RS; Grambsch P; Lopez JF Am J Psychiatry; 1988 Mar; 145(3):318-24. PubMed ID: 2830798 [TBL] [Abstract][Full Text] [Related]
13. Hypothalamic-pituitary-adrenocortical activity in patients with diabetes mellitus. Cameron OG; Kronfol Z; Greden JF; Carroll BJ Arch Gen Psychiatry; 1984 Nov; 41(11):1090-5. PubMed ID: 6497572 [TBL] [Abstract][Full Text] [Related]
14. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study. Stokes PE; Stoll PM; Koslow SH; Maas JW; Davis JM; Swann AC; Robins E Arch Gen Psychiatry; 1984 Mar; 41(3):257-67. PubMed ID: 6367690 [TBL] [Abstract][Full Text] [Related]
15. Disregulation of hypothalamic-pituitary-adrenal axis in the mentally retarded. Sandman CA; Barron JL; Parker L Pharmacol Biochem Behav; 1985 Jul; 23(1):21-6. PubMed ID: 4034619 [TBL] [Abstract][Full Text] [Related]
16. Hypothalamic-pituitary-adrenal axis hyperactivity is associated with decreased brain-derived neurotrophic factor in female suicide attempters. Ambrus L; Lindqvist D; Träskman-Bendz L; Westrin Å Nord J Psychiatry; 2016 Nov; 70(8):575-81. PubMed ID: 27216156 [TBL] [Abstract][Full Text] [Related]
17. The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test. Deuschle M; Schweiger U; Gotthardt U; Weber B; Körner A; Schmider J; Standhardt H; Lammers CH; Krumm B; Heuser I Biol Psychiatry; 1998 May; 43(10):762-6. PubMed ID: 9606531 [TBL] [Abstract][Full Text] [Related]
18. The dexamethasone suppression test in delusional depression. Further findings. Ayuso-Gutierrez JL; Almoguera MI; Garcia-Camba E; del Olmo Frias J; Cabranes JA J Affect Disord; 1985; 8(2):147-51. PubMed ID: 3157723 [TBL] [Abstract][Full Text] [Related]